The vaccine delivery devices market is estimated to be worth $1.5 billion by 2030, driven by the increase in global vaccination coverage. Data presented by the WHO indicates that the current global vaccination coverage is nearly 85%. Moreover, recent global immunization records indicate that more than 115 million children were immunized against diphtheria, tetanus and pertussis in 2018. As a result, significant efforts have been put into the development of drug delivery technologies / devices, s...

The companion diagnostics market revenue is estimated to be reach $6 billion by 2030, driven by the companion diagnostics for oncology market segment. Over the years, many cases have been identified where conventional treatment options have failed to demonstrate any therapeutic benefit. It is estimated that nearly 50% of prescribed drugs / therapies fail to show adequate clinical benefits. Further, a study of nearly 200 unique pharmacological interventions, across 670 clinical trials, concluded...

The global non-invasive prenatal testing and newborn screening market is likely be worth $8.2 billion by 2027, representing a CAGR of 15%. It has been estimated that close to 131 million babies are born each year across the globe. Of these, approximately 7.9 million are born with birth defects. In fact, more than 7,000 genetic disorders have been identified so far and the number is rising. Consequently, prenatal testing (primarily Non-invasive prenatal testing (NIPT)) and newborn screening have...

The smart wearables market, valued at USD 92.12 billion in 2024, is projected to grow to USD 113.7 billion in 2025 and USD 647.1 billion by 2035, representing a CAGR of 19.0% during the forecast period. Several start-ups, with innovative wearables, have surfaced in the past 6-7 years and have continuously encouraged the use of novel technologies. A sizeable proportion of these companies are focused on gaining foothold in the field of monitoring & diagnosis and wearables offering therapeutic bene...

The global intraocular pressure devices market is expected to reach USD 2.8 billion by 2026, growing at a CAGR of 83.9%. An imbalance in the production and / or drainage of aqueous humor within the eye is known to lead to an increase in intraocular pressure (IOP). Notably, it has been observed that this disease is controlled only in around 50% of patients who have been treated with some form of laser therapy; the effect usually wears off after a period of 5 years. Therefore, in the current scen...

The global infusion pumps market size is valued at USD 13.90 billion in 2025 and projected to grow from USD 14.87 billion 2026 to USD 25.39 billion in 2035, representing a CAGR of 6.1% during the forecast period 2026 to 2035. In terms of device type, volumetric pumps currently hold the largest share (30%) due to their high precision, safety, versatility, and broad applications in healthcare (including blood infusion, drug administration, fluid transmission during surgeries, nutrient delivery). A...

The overall anti counterfeit pharmaceutical packaging market is likely to be worth $420 million by 2025, growing at a CAGR of 7%. The major challenge associated with a counterfeit drug is that a non-expert, such as a patient, cannot differentiate between genuine and counterfeit drug without the help of a special instrument or device. These issues have led to the development of many technologies that can be used to detect whether a drug is legitimate or fake. Currently, the market can be categori...

The sustained release ocular drug delivery systems market is likely to be worth $6.95 billion by 2025. Given the intricacy of the anatomy and physiology of the eye, it is quite challenging to deliver an ophthalmic drug effectively to a specific ocular site. Approximately 95% of the drug, in topical eye drops, is lost due to several barriers. Consequently, this widening gap between the demand of novel treatments and supply of drugs/ systems is going to provide a major impetus to the sustained rel...

The oral thin films market, valued at USD 4.2 billion in 2024, is projected to grow to USD 4.5 billion in 2025 and USD 10.2 billion by 2035, representing a CAGR of 8.4% during the forecast period. Oral drug delivery technologies form an integral part of the pharmaceutical industry. From the conventional tablets / capsules to modern-day fast disintegrating and rapidly acting tablets / films, the market has come a long way. Lower bioavailability of oral solid drugs, inconvenience of administering...